The dandelion is to gardeners a common, pesky weed. But its seeds have a unique approach to flight that physicists have never seen before and could inform design.
Read more
Michael Schein: How did you end up working at the forefront of biology and technology?
Andrew Hessel: I have the strangest career ever. I originally got into the life sciences simply because all the other areas of technology just weren’t that interesting to me. Most technology falls apart and ends up in the junkyard. Cars rust. Even buildings can burn down. But biotech is different because even though organisms die, DNA gets passes on. Unfortunately, as I quickly learned, most scientists make really crappy money. So I thought: Let me find a way to pursue what I’m interested in but in a way that lets me make a good living. With that in mind, I’ve detoured into a medley of different technology companies. Eventually I made my way to work that’s at the intersection of biological research and computers. That’s how I ended up doing what I do now.
Schein: Tell us about the specific kind of biotech that takes up most of your headspace these days.
Read more
For many years, quantum computers were not much more than an idea. Today, companies, governments and intelligence agencies are investing in the development of quantum technology. Robert König, professor for the theory of complex quantum systems at the TUM, in collaboration with David Gosset from the Institute for Quantum Computing at the University of Waterloo and Sergey Bravyi from IBM, has now placed a cornerstone in this promising field.
Read more
The End of Moore’s Law?
Posted in computing, innovation
This video is the second in a multi-part series discussing computing. In this video, we’ll be discussing computing – more specifically, Moore’s Law with the exponential growth of technology due to our ability to pack more and more transistors into integrated circuits and the potential death of Moore’s Law!
[0:30–3:50] Starting off we’ll look at, how the integrated circuit has shaped the world due to our ability to pack more and more transistors into them, more specifically, in their usage in computing in the form of microprocessors (CPUs) and other computation related hardware.
[3:50–7:11] Following that we’ll discuss, how the transistor will continue to shrink onwards from this year, 2017 and the latest innovations that can shrink them even further, such as FinFETs.
Read more
Earlier this year, we hosted the Ending Age-Related Diseases 2018 conference at the Cooper Union in New York City. This conference was designed to bring together the best in the aging research and biotech investment worlds and saw a range of industry experts sharing their insights.
Dr. James Peyer is the founder and Managing Partner of Apollo Ventures, an early-stage life science investor and company builder that focuses on breakthrough technologies for treating age-related diseases.
He discusses the strategic paths to bringing longevity-promoting therapeutics to market as quickly as possible, with a particular focus on engaging pharmaceutical companies via disease-focused, proof-of-concept trials.
Read more
